Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 3Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pancreatic Neoplasms 2Esophageal Squamous Cell Carcinoma 2Squamous Cell Carcinoma of Head and Neck 1Neoplasm Metastasis 1Esophageal Neoplasms 1Adenocarcinoma 1

Interventions

pembrolizumab 6Cisplatin 6Magnetic Resonance Spectroscopy 4Docetaxel 4Specimen Handling 3Radiotherapy, Intensity-Modulated 3Platinum 3Cetuximab 31,2-diaminocyclohexaneplatinum II citrate 3(225)Ac-DOTA-c(RGDyK) 3atezolizumab 2Radiotherapy 2Immunoglobulin G 2Fluorouracil 2Fluorodeoxyglucose F18 2Disulfides 2Biopsy 2toripalimab 1nimotuzumab 1durvalumab 1bempegaldesleukin 1alfacalcidol 1acetyl-glycyl-asparagyl-glutaminyl-glutamyl-glutaminyl-valyl-seryl-prolyl-leucyl-threonyl-leucyl-leucyl-lysyl-lysyl-tryptophyl-cysteinyl-Alexa Fluoro 680 C2C2-maleimide conjugate 1X-Rays 1Sentinel Lymph Node Biopsy 1Radiotherapy, Image-Guided 1Photons 1Nivolumab 1Neck Dissection 1Fluconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Squamous Cell Carcinoma of Head and Neck × nimotuzumab × Clear all
NCT07535567 2026-04-30

NimoBenSeq

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase 2/3 Not yet recruiting
386 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡